Clinical meetings

← vista completa

Published on May 1, 2009 | http://doi.org/10.5867/medwave.2009.05.3919

Biological therapies in cancer: a new era in oncology

Terapias biológicas en cáncer: una nueva era en la oncología

Jorge Gutiérrez

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Jorge Gutiérrez

Clínica Las Condes, Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Gutiérrez J. Biological therapies in cancer: a new era in oncology. Medwave 2009;9(05):e3919 doi: 10.5867/medwave.2009.05.3919

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/05/2009

Index

Metrics

Not available at the moment.

Notes

References

  1. Goldman JM, Melo JV. Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001 Apr 5;344(14):1084-6. | CrossRef | PubMed
  2. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987 Jan 9;235(4785):177-82. | CrossRef | PubMed
  3. Khambata-Ford S, Garrett C, Meropol N, Basik M, Harbison C, Wu S, et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Onc 2007; 27:3230-7. | CrossRef | PubMed
  4. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004 Jun 3;350(23):2335-42. | CrossRef | PubMed